Tests ways to find different breast lesions before surgery
Part of Cancer, Skin clinical trials.
This trial looks at different methods doctors can use to locate a breast lesion using imaging, so it can be removed accurately during breast-conserving surgery. It may help your care team choose the best localization approach for your type and location of lesion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a consent form to join the study
- You have a cancerous breast lesion that your team plans to remove with breast-conserving surgery (not mastectomy as the first surgery)
- Your surgery plan includes imaging-guided localization to find the lesion (for example wires, ultrasound, radioactive seeds, or other tagged methods)
- You are 18 years old or older
- Your lesion type fits (DCIS or invasive cancer is allowed; multiple or both sides and neoadjuvant chemotherapy are allowed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new magnetic tracking method to help surgeons precisely locate breast tumors before surgery. It may help improve the accuracy of breast-conserving surgery.
This trial compares three ways to help surgeons find and remove breast tumors that can't be felt during surgery. It aims to see which method is most effective for breast-conserving surgery.
This trial looks at different drug combinations given before surgery to shrink breast tumors. The goal is to find which treatments work best for different types of breast cancer, such as triple-negative, HER2-positive, or hormone-receptor-positive. If you are a woman scheduled for neoadjuvant therapy (treatment before surgery) and have not had previous cancer treatment, this study may be for you.
This trial studies a new method (SAVI Scout) to help surgeons locate and remove breast tumors more precisely during surgery. It may reduce the need for multiple markers and improve outcomes.
This trial tests a device called OneMark that helps doctors find and track breast cancer during surgery and follow-up. It may help make sure the cancer is removed completely.
This study tests a way to decide whether women with early breast cancer and one or two affected lymph nodes can safely skip full lymph node removal. It uses a special biopsy to guide surgery and reduce side effects.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.